Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
about
Clinical application of genetics to guide prevention and treatment of oral diseasesHypoxia and VEGF mRNA expression in human tumorsTherapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways.Therapeutics role of olive fruits/oil in the prevention of diseases via modulation of anti-oxidant, anti-tumour and genetic activity.Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers.New molecular mediators in tumor angiogenesis.Progress and perspectives in chemoprevention of head and neck cancer.WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression.Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.Prognostic value of VEGF in human pancreatic ductal adenocarcinoma.Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer.Anti-angiogenic treatment of gastrointestinal malignancies.Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance.Update on molecular diagnostic tests in head and neck cancerMolecular pathogenesis of oral squamous cell carcinoma: implications for therapy.Molecular mechanisms of head and neck cancer.Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancerInostamycin prevents malignant phenotype of cancer: inhibition of phosphatidylinositol synthesis provides a therapeutic advantage for head and neck squamous cell carcinoma.Correlation of lymphatic vessel density and vascular endothelial growth factor with nodal metastasis in papillary thyroid microcarcinoma.Targeted therapy in head and neck cancer.Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis.The VEGF pathway in lung cancer.Predicting lymph node metastasis in patients with papillary thyroid carcinoma by vascular index on power Doppler ultrasound.Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.The effects of reactive species on the tumorigenic phenotype of human head and neck squamous cell carcinoma (HNSCC) cells.Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma.Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.Dynamic contrast-enhanced computed tomography for the quantification of tumor response to vasoactive agents in a rat tumor model: preliminary results.Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.Stage-dependent expression of an angiogenic agent and vascular organization in experimental skin tumor development.Precision Therapy of Head and Neck Squamous Cell Carcinoma.Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients
P2860
Q26999507-7D6E9016-5077-41EE-8DEF-A31FE1A8D474Q28344471-DEEE10DF-B608-4639-A9ED-C0667D1D0277Q33736242-0A70841E-3138-43D5-9CBA-DB9D946E22E2Q33756187-961B0F9B-C5C0-4890-9351-BD781FB10D71Q34608643-6C2D794C-D82F-46B8-BEEB-8F419E9E1E06Q34687698-1DD75630-E77F-4D92-B946-94D6814ED355Q35160205-35190485-451D-41A0-BC94-A25C7087777FQ35551984-33F375AD-5724-4ADD-BD33-8A994D9E0498Q35587630-E68EE376-3150-4187-98AA-1FFA9AF1BA05Q35746653-15807A1A-E4BA-4381-B0B2-7B3B3C40039BQ35936830-BFCC10DA-F14E-4132-B528-3D8EFBA76C1AQ36297882-1140B2BD-B7A8-413B-AD12-1FA2B4D4B79BQ36353516-0BDC59C8-5099-4C3D-8851-A4D1005FC9DCQ36614158-D5252163-5432-44C3-B8A6-9371535FB255Q36798480-A944DC8B-0FCC-44EE-86B0-968BEF7796D4Q37039386-939A3B75-C182-47AC-A003-222FCF42E64AQ37159537-B05A850F-B0A1-4697-A1E6-FBFF2BE967EBQ37590247-BF6F8BDE-D193-42DA-8E27-4960A7897B0CQ37673218-24C52E11-EAE7-4CF5-9537-CA8437585201Q37919779-9DAD6409-0269-4047-A7D8-CC3D58CD8C83Q37988981-65E47353-4DF2-459A-B345-AA952618583BQ38044324-6AFDD9DB-77FC-4A93-9896-FCBAD0B59605Q38148460-28E89F97-2914-457C-AC3F-A2DDE42AC03CQ38410144-85EF71D8-DFF6-45DA-9A03-D8D18D61223DQ38697010-7CF8090A-DDD1-46DF-A2E4-99A6CF7F0192Q38778874-E0B64FD1-8F78-4D47-9B6D-33DE95E1F152Q39001479-14D83A0A-0886-42AC-946B-EC7CF30E60F6Q39079661-F759036E-1C46-41C5-BDFA-D436F743C882Q39670476-05327291-67FA-4649-B7EC-069F7C2DBCB1Q40196342-A65C4312-3F69-43B6-91BF-BF01CD08A8A1Q42454728-E4A26DEC-BB71-43E8-A2AC-AB1E932B8DC3Q52591781-84D418F4-8276-46BB-88C6-8026A6FE1BFAQ53271209-7173D87C-DBBC-4A2B-8ECC-11CA6F08FB7CQ58251307-C4BC8DBA-EC30-4AC2-9FE7-9A560B083822
P2860
Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Prognostic value of vascular e ...... neck squamous cell carcinomas
@ast
Prognostic value of vascular e ...... neck squamous cell carcinomas
@en
type
label
Prognostic value of vascular e ...... neck squamous cell carcinomas
@ast
Prognostic value of vascular e ...... neck squamous cell carcinomas
@en
prefLabel
Prognostic value of vascular e ...... neck squamous cell carcinomas
@ast
Prognostic value of vascular e ...... neck squamous cell carcinomas
@en
P2093
P2860
P356
P1476
Prognostic value of vascular e ...... neck squamous cell carcinomas
@en
P2093
Takebayashi S
Wennerberg J
P2860
P2888
P304
P356
10.1054/BJOC.2000.1357
P407
P577
2000-09-01T00:00:00Z
P5875
P6179
1047406779